Bulldog Investors’s Clarus Therapeutics Holdings, Inc. Warrants CRXTW Stock Holding History

Bulldog Investors’s Portfolio CRXTW Stock Details CRXTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-14,011	Closed	-$1K	–	362
2022 Q2	$1K	Sell	14,011 -28,590	-67%	-$2.81K	﹤0.01%	335
2022 Q1	$6K	Sell	42,601 -657	-2%	-$119	﹤0.01%	326
2021 Q4	$12K	Sell	43,258 -332	-0.8%	-$170	﹤0.01%	279
2021 Q3	$33K	Sell	43,590 -2,800	-6%	-$2.11K	0.01%	237
2021 Q2	$35K	Sell	46,390 -23,610	-34%	-$14.8K	0.01%	235
2021 Q1	$38K	Buy	+70,000	New	+$56K	0.01%	202

Other funds holding CRXTW

MSU

Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return

Bulldog Investors's CRXTW Position: Q3 2022 in Review

Bulldog Investors sold out of Clarus Therapeutics Holdings, Inc. Warrants (CRXTW) in Q3 2022, closing a stake of 14,011 shares — an estimated $1K sold.

Bulldog Investors first reported a position in CRXTW in Q1 2021 and held it in 6 quarters. The position peaked at $38K in Q1 2021. 5 funds tracked by Wall St. Rank hold CRXTW as of Q3 2022.

Bulldog Investors reported no remaining Clarus Therapeutics Holdings, Inc. Warrants position as of Q3 2022 after selling out during the quarter.
Bulldog Investors sold 14,011 Clarus Therapeutics Holdings, Inc. Warrants shares in Q3 2022, an estimated $1K.
Bulldog Investors first reported a position in Clarus Therapeutics Holdings, Inc. Warrants in Q1 2021 and held it in 6 quarters.
Bulldog Investors's Clarus Therapeutics Holdings, Inc. Warrants position peaked at $38K in Q1 2021.
5 funds tracked by Wall St. Rank held Clarus Therapeutics Holdings, Inc. Warrants as of Q3 2022.

Based on Bulldog Investors's 13F filing for Q3 2022, filed 14 Nov 2022.